CAAS Capital Management’s Bioventus BVS Stock Holding History

CAAS Capital Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250,000	Closed	-$3.82M	–	1059
2021 Q1	$3.82M	Buy	+250,000	New	+$3.56M	0.04%	418

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CAAS Capital Management's BVS Position: Q2 2021 in Review

CAAS Capital Management sold out of Bioventus (BVS) in Q2 2021, closing a stake of 250,000 shares — an estimated $3.82M sold.

CAAS Capital Management first reported a position in BVS in Q1 2021 and held it in 1 quarter. The position peaked at $3.82M in Q1 2021. 53 funds tracked by Wall St. Rank hold BVS as of Q2 2021.

CAAS Capital Management reported no remaining Bioventus position as of Q2 2021 after selling out during the quarter.
CAAS Capital Management sold 250,000 Bioventus shares in Q2 2021, an estimated $3.82M.
CAAS Capital Management first reported a position in Bioventus in Q1 2021 and held it in 1 quarter.
CAAS Capital Management's Bioventus position peaked at $3.82M in Q1 2021.
53 funds tracked by Wall St. Rank held Bioventus as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.